Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

NCT01834742 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: NER1006
DRUG: NER1006
DRUG: NER1006
DRUG: Moviprep
DRUG: NER1006
DRUG: NER1006
DRUG: NER1006
DRUG: NER1006

Sponsor

Norgine

Collaborators

[object Object]